Trevi Therapeutics to Present at Stifel Healthcare Conference
NEW HAVEN, Conn., Nov. 13, 2019 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, today announced that management will present a […]